US provider directory / Profile

IVIM Health

Virtual weight-care membership advertising compounded and brand-name access alongside clinician and community support.

Leer el resumen en español ↓
  • Insurance help
  • Brand route
  • Coaching
  • Switching support
Research checkedSep 13, 2026
2 cited sourcesUS profile
Editorial note

This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.

At a glance

Price view$75/month membership; medication separateThe first membership month is advertised free. Six-month compounded offers were displayed from $75/month semaglutide and $133/month tirzepatide, separate from the membership unless checkout says otherwise.
Payment routesCash pay · Insurance helpConfirm which products use insurance and what navigation service is included.
Medicines and brand contextSemaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes) · Liraglutide (Saxenda; Victoza for type 2 diabetes)Only if prescribed, appropriate, and available for the relevant indication.
GeographyUS multi-state; confirm at intakeConfirm during intake.
Service modelMembership plus selected treatmentTelehealth program
Format and supportInjection · Oral medicineCoaching · Clinician support · Switching pathway · Home delivery
Evidence reviewed2 cited sources

Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.

Still to confirm4 open checks

An open check means the public sources were not specific enough—not that the service failed the check.

Resumen en español

IVIM Health para usuarios hispanohablantes

Idioma de la consulta no confirmado

Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.

Mercado revisadoEstados Unidos
Forma de pagoPago directo · Seguro médico
Ruta publicadaMedicamento de marca · Preparación compuesta
Idioma de la atención

No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.

Antes de pagar, confirma:
  • si la cita concreta será en español;
  • el coste mensual ordinario y qué incluye;
  • la licencia estatal del profesional;
  • el medicamento, la farmacia y el coste por separado.

Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.

Comparar proveedores para hispanohablantes en EE. UU. →

How the program is structured

A $75 monthly membership with same-day access, unlimited provider visits, health coaching, and a mixed menu of compounded and FDA-approved brands. Multi-month compounded offers lower the effective medication price but add prepayment commitment.

GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.

Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.

Research confidence Medium Confidence reflects public-source specificity, not clinical quality.

Service configuration

These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.

Provider type
Telehealth program
Medicine context
Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes) · Liraglutide (Saxenda; Victoza for type 2 diabetes)
Formats reviewed
Injection · Oral medicine
Funding routes
Private pay · Insurance support
Service features
Coaching · Clinician support · Switching pathway · Home delivery
Access check
Confirm current state access
Evidence status
Primary sources reviewed
Research depth
2 cited sources · 3 medicine rows · 4 open checks

Recurring cost breakdown

  • $75/month membership with the first month advertised free.
  • Six-month compounded semaglutide headline: $75/month effective; compounded tirzepatide: $133/month effective.
  • Brand medication price or copay is separate and route-dependent.
  • Compare the full prepaid total and renewal, not only the effective monthly headline.
Build the actual monthly total from
  • Medicine + dose
  • Membership or consultation
  • Delivery + supplies
  • Labs + follow-up
  • Renewal after offers

Medication and formulation matrix

MedicationFormRegulatory / program pathPublished price view
Compounded semaglutide / tirzepatideWeekly injectionNot FDA-approvedSix-month effective rates from $75 / $133 + membership
Wegovy / Zepbound / FoundayoPill or injectionFDA-approved brandsCash or insurance; verify
Ozempic / Mounjaro / Saxenda / liraglutideInjectionBrand/generic and indication varyRoute-specific

Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.

State-by-state availability

  • IVIM advertises nationwide virtual access; treatment availability still varies by state.
  • Confirm the selected product before purchasing a multi-month plan.

Clinician access and follow-up cadence

  • Same-day provider visits are advertised.
  • Membership includes unlimited provider visits, functional-health coaching, and support.
  • Refill and monitoring timing depends on treatment.

Pharmacy and fulfillment

  • Prescription fulfillment uses partner pharmacies.
  • The named pharmacy by product/state was not confirmed on the main program page.

Insurance and prior authorization

  • Both insurance and cash options are marketed.
  • Prior authorization and actual copay are plan-specific.

Cancellation, refund, and commitment

  • The membership and any prepaid medication bundle can have distinct renewal and refund rules.
  • Read the returns/refunds page before a six-month prepayment.

Labs, monitoring, and dose management

  • A universal included lab panel was not confirmed.
  • Functional-health services do not establish that all labs are included in the GLP-1 price.

Maintenance and switching

  • Unlimited visits may support ongoing management.
  • For switching, confirm accepted records, dose, prescription timing, and whether a prepaid offer applies to established-dose patients.

Program snapshot

Care model

Membership plus selected treatment

Profiled support: Ongoing clinician access, Coaching or behavior support.

Payment and coverage

Cash pay · Insurance help

Confirm which products use insurance and what navigation service is included.

Pharmacy and fulfillment

Verify before purchase

Ask for the dispensing pharmacy for the selected treatment and state.

What the advertised program may include

  • Clinical evaluation
  • Digital care team
  • Community or support tools
  • Medication access when prescribed

Useful comparison signals

Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.

  • Starting care and comparing first-provider requirements
  • Switching providers or continuing an established treatment
  • Ongoing clinician access
  • Coaching or behavior support

Open evidence gaps

These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.

  • Named pharmacy by product
  • State-by-product matrix
  • Universal lab inclusion
  • Refund formula for every prepaid offer

Questions to ask before paying

  1. What is the ordinary recurring total after any introductory period?
  2. Does that total include clinician care, medication, supplies, labs, and shipping?
  3. Which clinician group and dispensing pharmacy will be responsible for my care?
  4. What happens to billing if I am not prescribed the advertised treatment?
  5. What records and timing do you require if I am switching from another provider?

Source ledger

Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.